Objective: To evaluate different doses of ivermectin in adult patients with mild COVID-19 and
to evaluate the effect of ivermectin on mortality and clinical consequences. Methods: A …

Researchers around the world are working at record speed to find the best ways to treat and
prevent coronavirus disease 2019 (COVID‐19). This study aimed to evaluate the efficacy of …

Purpose Given the coronavirus disease 2019 (COVID-19) pandemic, there is a global
urgency to discover an effective treatment for patients withthis disease. This study aimed to …

Background Ivermectin which was widely considered as a potential treatment for COVID-19,
showed uncertain clinical benefit in many clinical trials. Performing large-scale clinical trials …

Background and objectives: Various existing non-antiviral drugs are being used to treat
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection based mostly on …

During the first year of the COVID-19 pandemic, unauthorized drugs were widely used.
Ivermectin and hydroxychloroquine are drugs that inhibit viral replication in vitro and that …

Background and objectives An effective treatment option is not yet available for SARS-CoV2,
which causes the COVID-19 pandemic and whose effects are felt more and more every day …

Background To date no effective therapy has been demonstrated for COVID-19. In vitro,
studies indicated that ivermectin (IVM) has antiviral effect. Objectives To assess the …

Objective Ivermectin has been suggested as a treatment for COVID-19. This randomised
control trial was conducted to test the efficacy of Ivermectin in the treatment of mild and …

Objective We evaluated whether ivermectin combined with doxycycline reduced the clinical
recovery time in adults with COVID-19 infection. Methods This was a randomized, blinded …